George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWag Payment Regulatory News (WPS)

Share Price Information for Wag Payment (WPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.20
Bid: 65.20
Ask: 66.40
Change: -1.00 (-1.51%)
Spread: 1.20 (1.84%)
Open: 69.20
High: 69.20
Low: 65.00
Prev. Close: 66.20
WPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

8 Oct 2021 07:00

RNS Number : 4320O
Morgan Stanley & Co. Int'l plc
08 October 2021
 

8 October 2021

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

W.A.G payment solutions plc

Pre-Stabilisation Notice

Morgan Stanley & Co. International plc (contact: James Manson-Bahr; telephone: +44 20 7425-3672) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052 and/or the UK FCA Stabilisation Binding Technical Standards. Stabilisation transactions aim at supporting the market price of the securities during the stabilisation period. Stabilisation may not necessarily occur and it may cease at any time.

Securities

Issuer:

W.A.G payment solutions plc (the "Company" or "Eurowag")

ISIN:

GB00BLGXWY71

Description:

Initial Public Offering

Offer size:

124,000,000 ordinary shares (excluding the overallotment option)

Offer price:

150 pence per ordinary share

Stabilisation

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Stabilisation period expected to start on:

8 October 2021

Stabilisation period expected to end no later than:

5 November 2021

Stabilisation trading venue:

London Stock Exchange, Over-the-Counter (OTC) and other trading venues

Over-allotment & Greenshoe Option:

Terms:

In connection with the Offer, Morgan Stanley, as Stabilising Manager, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares up to a maximum of 10% of the total number of the Offer Shares (prior to any exercise of the Over-allotment Option) or effect other transactions with a view to supporting the market price of the Ordinary Shares at a level higher than that which might otherwise prevail in the open market for a period of no more than 30 calendar days after the date of commencement of conditional dealings of the shares on the London Stock Exchange. Such transactions may be effected on the London Stock Exchange, in the over-the-counter markets or otherwise. There is no obligation on the Stabilising Manager to undertake stabilisation transactions. Such transactions, if commenced, may be discontinued at any time without prior notice and must be brought to an end no later than 30 calendar days after the date of commencement of conditional dealings of the Ordinary Shares on the London Stock Exchange (the "Stabilisation Period"). In no event will measures be taken to stabilise the market price of the Ordinary Shares above the Offer Price. Save as required by law, the Stabilising Manager does not intend to disclose the extent of any stabilisation transactions under the Offer.

For the purposes of allowing the Stabilising Manager to cover short positions resulting from any such over-allocations and/or from sales of Ordinary Shares effected by it during the Stabilisation Period, it is expected that certain shareholders of the Company will grant to the Stabilising Manager the Overallotment Option, pursuant to which the Stabilising Manager may purchase or procure purchasers for up to a maximum of 10% of the total number of Ordinary Shares comprised in the Offer (the "Over-allotment Shares") at the Offer Price. The Over-allotment Option shall be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings in the Ordinary Shares on the London Stock Exchange.

Any Over-allotment Shares made available pursuant to the Over-allotment Option will rank pari passu in all respects with the Ordinary Shares, including for all dividends and other distributions declared, made or paid on the Ordinary Shares, will be purchased on the same terms and conditions as the Ordinary Shares in the Offer and will form a single class for all purposes with the other Ordinary Shares.

Number of shares covered by Over-allotment Option:

12,400,000 Ordinary Shares

Duration:

This option may be executed in full or in part at any time during the Stabilisation Period.

 

Important Notice:

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAMRBBTMTIMTPB
12
Date   Source Headline
1st Jul 20227:00 amRNSEurowag completes the acquisition of WebEye assets
23rd Jun 20227:00 amRNSUpdate on completion of WebEye assets acquisition
26th May 20223:54 pmRNSResult of AGM
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSUpdate on the acquisition of WebEye’s assets
5th May 20227:00 amRNSTrading Update
1st Apr 20227:54 amRNSAnnual Report and Notice of AGM
24th Mar 20227:00 amRNSPreliminary Results for year ended 31 Dec 2021
17th Mar 20229:57 amRNSChange of Registered Office
11th Mar 20225:58 pmRNSUpdate on the potential acquisition of WebEye
4th Mar 20229:44 amRNSNotice of Preliminary Results
17th Jan 20227:00 amRNSTrading Update
30th Dec 202112:25 pmRNSChange of Director Responsibilities
8th Dec 20214:37 pmRNSDirector/PDMR Shareholding
24th Nov 20219:42 amRNSDirector/PDMR Shareholding
16th Nov 20217:00 amRNSAppointment of Joint Corporate Brokers
15th Nov 20217:00 amRNSAcquisition of WebEye
11th Nov 20215:13 pmRNSStabilisation Notice
9th Nov 20213:15 pmRNSStabilisation Notice
8th Nov 20211:18 pmRNSStabilisation Notice
5th Nov 20211:18 pmRNSStabilisation Notice
2nd Nov 20211:20 pmRNSStabilisation Notice
1st Nov 20214:13 pmRNSTotal Voting Rights
1st Nov 20213:04 pmRNSStabilisation Notice
29th Oct 20211:40 pmRNSStabilisation Notice
26th Oct 20211:02 pmRNSStabilisation Notice
18th Oct 202112:27 pmRNSDirector/PDMR Shareholding
15th Oct 20216:18 pmRNSDirector/PDMR Shareholding
14th Oct 20215:33 pmRNSDirector/PDMR Shareholding
14th Oct 20215:32 pmRNSDirector/PDMR Shareholding
13th Oct 20218:00 amRNSAdmission to Trading on the London Stock Exchange
8th Oct 20217:00 amRNSStabilisation Notice
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.